Scientists from EPFL and ETHZ have developed a powerful tool for exploring and determining the inherent biological differences between individuals, which overcomes a major hurdle for personalized medicine.
One of the biggest obstacles in successfully treating metabolic disorders such as diabetes, obesity, fatty liver etc, is the variation in the way patients respond to medication. The key to this variation lies in the inherent biological differences between individuals, which cannot all be explained genetically. At the same time, this variation makes it very difficult to develop “standard” treatments for certain diseases. In a groundbreaking initiative, EPFL and ETHZ scientists have developed a strategy that can define and explain metabolic differences between individuals, essentially paving the way for precision medicine. The work, which also highlights significant issues with animal-based drug studies, is published in Science.
We are increasingly learning that medical interventions can be more successful when they are tailored to the specific profile of the individual patient. The problem is that defining that profile is extremely difficult, as it involves information on the person’s genome, proteins, fats, and all sorts of other layers of biology that make up their tissues and body. And so far, the only differences that we have been seriously taking into account are those found between genes.
This is what the labs of Johan Auwerx at EPFL and Ruedi Aebersold at ETH Zurich set out to solve with their recently published study. Looking at 40 different mice strains, the researchers successfully connected the variation between individuals’ genomes to the variation between their proteomes — their full set of proteins. In this way, they took a giant leap in profiling the biology of a particular individual.
“There is a black box between a patient’s genome and their disease,” says Johan Auwerx, whose lab handled the genome side of the study. “What we have done here is find a way to fill the black box by obtaining information on the patient’s proteome.”
“It’s much more complex to measure the set of proteins than to sequence the entire genome,” says Yibo Wu, co-lead author of the study. The scientists used protein data from mice, which they obtained from a new mass spectrometry technique that Aebersold’s group developed, known as SWATH-MS. This is a technique that combines the advantages of high-throughput mass spectrometry with high reproducibility and consistency. In short, it is able to identify thousands of different proteins in hundreds of samples much faster and accurately than conventional techniques, allowing the researchers to measure the concentrations of a broad spectrum of liver proteins in the mice.
The researchers measured a total of 2,600 different proteins from tissue samples of 40 mice strains, all of which came from the same two ancestors, meaning that they were genetically related to each other. “We wanted to keep the genetics simple in order to observe differences in the impact of environment (diet) on the proteome, other layers of biology, and their predisposition to develop diseases,” says Auwerx.
The mice were divided into groups of representing each of the 40 strains, and the groups were fed either a high-fat diet – essentially junk food – or a healthy, low-fat diet. Over a few weeks, the scientists charted the mice’s physiological data, and tested how fast they could gain weight on the junk-food diet and lose weight by exercising. Despite their similar genetic make-up, the mice on the high-fat diet showed varied responses to diet and exercise. For example, some developed metabolic disorders like fatty liver, while others did not.
The researchers then combined the physiological data with data for their genome, their proteome, and their transcriptome, which is essentially their full set of RNAs — another biological “layer” in the black box. Through this combination, the scientists were able to better understand the role several proteins play when it comes to metabolizing fat and producing energy from it.
“Like the mouse strains in this study, each patient with a disease is genetically different”, says Ruedi Aebersold. “The approach we used in the mouse cohort can now be applied one-for-one in research on human diseases, and particularly for personalized medicine.” The SWATH-MS approach is now ready to use in human cohort studies, as the researchers in his group have produces a corresponding database for thousands of human proteins.
“The aim here is to be able to customise medical intervention for each patient based on their individual biological makeup, the ‘black box’,” says Auwerx. In this vein, his group is now looking at specific drugs that can be used more effectively with this approach to treat metabolic disorders.
Learn more: New tool brings personalized medicine closer
The Latest on: Personalized medicine
via Google News
The Latest on: Personalized medicine
- The Challenge of Precision Medicine in mCRPC on February 18, 2019 at 6:20 am
Over the past decade, we have used the terms personalized medicine and precision medicine interchangeably. For the most part, patient care has always been personalized. Yes, some want to make it more ... […]
- The Future of Medicine is at the Nanoscale on February 15, 2019 at 1:56 pm
Personalized healthcare is the Holy Grail of medicine—the idea that every illness or disease can be treated on an individual basis for each patient, with medicines, drugs and treatments designed for e... […]
- ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia on February 15, 2019 at 9:24 am
anthropologic genetics and personalized medicine. ISABS Scientific Committee comprises four Nobel Laureates and world's top physicians and scientists. According to U.S. News & World Report, Mayo Clini... […]
- AI and personalized medicine to raise the bar in radiology reporting on February 14, 2019 at 9:10 pm
RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wh... […]
- Microarray Analysis Market - Global Forecast to 2023: Use of Microarrays in Personalized Medicine Present Opportunities on February 14, 2019 at 5:49 am
personalized medicine, genetic disease diagnosis, and various diseases. Asia Pacific is estimated to register the highest CAGR during the study period. In this report, the microarray analysis ... […]
- FDA approved record number of personalized medicines in 2018: report on February 13, 2019 at 12:53 pm
The Personalized Medicine at FDA: A Progress & Outlook Report (PDF) gives credit to the FDA for accelerating the trend of patients and payers embracing personalized medicine. In fact, personalized med... […]
- Biomarker Deals Report on Personalized Medicine and Companion Diagnostics for North America and Europe Region just published on February 12, 2019 at 11:41 pm
Size of the biomarker deals market report with technologies updates, estimate size of various other dependent submarkets. Major players in market were identified through secondary research and their m... […]
- Scott LaFee: Medicine Goes to the Dogs, Precisely on February 12, 2019 at 2:36 pm
Precision or personalized medicine is the mantra these days. It’s the idea that medical science can use tools like genetic sequencing to better understand your specific ailment and how best to treat i... […]
- Myriad to Present New Data for Its Expanded Carrier and Noninvasive Prenatal Screens at the 2019 Society for Maternal-Fetal Medicine Annual Meeting on February 8, 2019 at 4:59 am
SALT LAKE CITY, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (MYGN), a global leader in molecular diagnostics and personalized medicine, today announced that its Myriad Women’s Health ... […]
- ‘A major step forward for personalized nutrition’: Viome to acquire Habit from Campbell Soup on February 7, 2019 at 6:06 am
Commenting independently on the news, Jeffrey Bland, PhD, President of the Personalized Lifestyle Medicine Institute (PLMI) , welcomed the news, telling us: “The report of the acquisition of Habit by ... […]
via Bing News